Ultragenyx Pharmaceutical (RARE) Other Non-Current Assets (2013 - 2026)
Ultragenyx Pharmaceutical's Other Non-Current Assets came in at $63 million for Q2 2026, up 4.8% from $60.12 million a year earlier and up 3.3% from the prior quarter.
Ultragenyx Pharmaceutical (RARE) Other Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Other Non-Current Assets was $60 million, down 4.8% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 46.8% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $63 million in FY2024 (+9.2%), $57.69 million in FY2023 (+19.3%), $48.34 million in FY2022 (+135.1%) and $20.56 million in FY2021 (+133.3%).
- Year-over-year, Other Non-Current Assets increased in six of the last eight quarters, with growth averaging 15.4%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q3 2021 (growth of 222.4%), and the weakest in Q4 2025 (a decline of 4.8%).
- Business Quant data shows RARE's Other Non-Current Assets at $61 million (Q1 2026), $60 million (Q4 2025) and $57.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | 63.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.00 Mn |
| Mar 31, 2026 | 61.00 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 57.86 Mn |
| Jun 30, 2025 | 60.12 Mn |
| Mar 31, 2025 | 62.37 Mn |
| Dec 31, 2024 | 63.00 Mn |
| Sep 30, 2024 | 53.87 Mn |
| Jun 30, 2024 | 53.77 Mn |
| Mar 31, 2024 | 59.97 Mn |
| Dec 31, 2023 | 57.69 Mn |
| Sep 30, 2023 | 27.90 Mn |
| Jun 30, 2023 | 26.49 Mn |
| Mar 31, 2023 | 22.26 Mn |
| Dec 31, 2022 | 48.34 Mn |
| Sep 30, 2022 | 18.29 Mn |
| Jun 30, 2022 | 21.14 Mn |
| Mar 31, 2022 | 21.22 Mn |
| Dec 31, 2021 | 20.56 Mn |
| Sep 30, 2021 | 16.42 Mn |
Ultragenyx Pharmaceutical Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();